K2M Group Holdings, Inc. (KTWO) Shares Bought by Schwab Charles Investment Management Inc.

Schwab Charles Investment Management Inc. grew its position in shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) by 32.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 174,070 shares of the medical device company’s stock after purchasing an additional 42,290 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.41% of K2M Group Holdings worth $4,241,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of KTWO. Legal & General Group Plc grew its position in shares of K2M Group Holdings by 9.1% during the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after purchasing an additional 564 shares in the last quarter. American International Group Inc. grew its position in shares of K2M Group Holdings by 7.1% during the first quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after purchasing an additional 1,047 shares in the last quarter. Campbell & CO Investment Adviser LLC purchased a new position in shares of K2M Group Holdings during the second quarter valued at about $415,000. Bank of America Corp DE grew its position in shares of K2M Group Holdings by 38.3% during the first quarter. Bank of America Corp DE now owns 25,381 shares of the medical device company’s stock valued at $521,000 after purchasing an additional 7,023 shares in the last quarter. Finally, Tudor Investment Corp ET AL grew its position in shares of K2M Group Holdings by 50.3% during the first quarter. Tudor Investment Corp ET AL now owns 31,420 shares of the medical device company’s stock valued at $644,000 after purchasing an additional 10,519 shares in the last quarter. Hedge funds and other institutional investors own 97.77% of the company’s stock.

K2M Group Holdings, Inc. (NASDAQ:KTWO) opened at 19.42 on Tuesday. The company’s market cap is $840.26 million. K2M Group Holdings, Inc. has a one year low of $16.32 and a one year high of $25.99. The company has a 50 day moving average of $21.53 and a 200-day moving average of $22.50.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The company had revenue of $65.70 million during the quarter, compared to analysts’ expectations of $66.26 million. During the same quarter in the prior year, the company earned ($0.27) EPS. K2M Group Holdings’s revenue was up 11.0% compared to the same quarter last year. On average, equities analysts expect that K2M Group Holdings, Inc. will post ($0.82) earnings per share for the current fiscal year.

A number of research analysts have recently weighed in on the company. ValuEngine lowered K2M Group Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Zacks Investment Research upgraded K2M Group Holdings from a “sell” rating to a “hold” rating in a research report on Saturday, August 5th. Cowen and Company restated a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a research report on Wednesday, July 19th. William Blair restated an “outperform” rating on shares of K2M Group Holdings in a research report on Tuesday, October 10th. Finally, BidaskClub lowered K2M Group Holdings from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $25.60.

In other news, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $26,247.20. Following the completion of the sale, the insider now owns 201,961 shares of the company’s stock, valued at approximately $4,863,220.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Gregory S. Cole sold 39,357 shares of the stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $23.37, for a total transaction of $919,773.09. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 44,129 shares of company stock valued at $1,033,644. 5.80% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “K2M Group Holdings, Inc. (KTWO) Shares Bought by Schwab Charles Investment Management Inc.” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and republish

Several other institutional investors have also recently modified their holdings of KTWO. Legal & General Group Plc grew its position in shares of K2M Group Holdings by 9.1% during the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock valued at $138,000 after purchasing an additional 564 shares in the last quarter. American International Group Inc. grew its position in shares of K2M Group Holdings by 7.1% during the first quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock valued at $325,000 after purchasing an additional 1,047 shares in the last quarter. Campbell & CO Investment Adviser LLC purchased a new position in shares of K2M Group Holdings during the second quarter valued at about $415,000. Bank of America Corp DE grew its position in shares of K2M Group Holdings by 38.3% during the first quarter. Bank of America Corp DE now owns 25,381 shares of the medical device company’s stock valued at $521,000 after purchasing an additional 7,023 shares in the last quarter. Finally, Tudor Investment Corp ET AL grew its position in shares of K2M Group Holdings by 50.3% during the first quarter. Tudor Investment Corp ET AL now owns 31,420 shares of the medical device company’s stock valued at $644,000 after purchasing an additional 10,519 shares in the last quarter. Hedge funds and other institutional investors own 97.77% of the company’s stock.

K2M Group Holdings, Inc. (NASDAQ:KTWO) opened at 19.42 on Tuesday. The company’s market cap is $840.26 million. K2M Group Holdings, Inc. has a one year low of $16.32 and a one year high of $25.99. The company has a 50 day moving average of $21.53 and a 200-day moving average of $22.50.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings data on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The company had revenue of $65.70 million during the quarter, compared to analysts’ expectations of $66.26 million. During the same quarter in the prior year, the company earned ($0.27) EPS. K2M Group Holdings’s revenue was up 11.0% compared to the same quarter last year. On average, equities analysts expect that K2M Group Holdings, Inc. will post ($0.82) earnings per share for the current fiscal year.

A number of research analysts have recently weighed in on the company. ValuEngine lowered K2M Group Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Zacks Investment Research upgraded K2M Group Holdings from a “sell” rating to a “hold” rating in a research report on Saturday, August 5th. Cowen and Company restated a “buy” rating and set a $26.00 price objective on shares of K2M Group Holdings in a research report on Wednesday, July 19th. William Blair restated an “outperform” rating on shares of K2M Group Holdings in a research report on Tuesday, October 10th. Finally, BidaskClub lowered K2M Group Holdings from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $25.60.

In other news, insider John Philip Md Kostuik sold 1,090 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $26,247.20. Following the completion of the sale, the insider now owns 201,961 shares of the company’s stock, valued at approximately $4,863,220.88. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Gregory S. Cole sold 39,357 shares of the stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $23.37, for a total transaction of $919,773.09. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 44,129 shares of company stock valued at $1,033,644. 5.80% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “K2M Group Holdings, Inc. (KTWO) Shares Bought by Schwab Charles Investment Management Inc.” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://ledgergazette.com/2017/10/17/k2m-group-holdings-inc-ktwo-shares-bought-by-schwab-charles-investment-management-inc.html.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Want to see what other hedge funds are holding KTWO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for K2M Group Holdings, Inc. (NASDAQ:KTWO).

Institutional Ownership by Quarter for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply